CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Home sleep apnea test +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05516524
NCT05516524N/ACompleted

Home Sleep Apnea Testing for the Evaluation of Obstructive Sleep Apnea in Children Following Management With Adenotonsillectomy

Children's Hospital of Philadelphia·interventional·Posted Aug 25, 2022·Updated Oct 14, 2025

In Brief

A clinical study evaluating Home sleep apnea test and PSG for Sleep Apnea, Obstructive and 3 related conditions. Completed, enrolled 62 participants across 1 site.

Detailed Summary

This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 25, 2022
Enrollment StartDec 1, 2022
Primary CompletionSep 10, 2025
Study CompletionSep 17, 2025
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 3.9 years ago

Interventions

Home sleep apnea testother

Level II home sleep apnea testing evaluates for obstructive sleep apnea in the home environment with parental supervision.

PSGother

Overnight sleep study in the sleep laboratory with continuous monitoring by clinical staff.